SPRY News

ROSEN, REGARDED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY

Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Urged to Join Class Action Before October 5, 2026 – Contact Levi & Korsinsky

Pomerantz LLP Calls Attention to Class Action Against ARS Pharmaceuticals, Inc. – SPRY

Pomerantz LLP Calls Attention to Class Action Against ARS Pharmaceuticals, Inc. – SPRY

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY

Securities Fraud Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Reminds Investors of October 5, 2026

Pomerantz LLP Alerts Shareholders to Investor Suit Involving ARS Pharmaceuticals, Inc. – SPRY

SPRY Investors Have Rights – If You Lost Money Investing in ARS Pharmaceuticals Inc. Contact Robbins LLP for Information Recovering Your Losses

ARS Pharmaceuticals, Inc. (SPRY) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 5, 2026

SPRY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!